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Abstract 
Background: Suicide is one of the main causes of excess of premature death in psychotic patients. Published stud-
ies found that suicide risk begins in ultra-high risk of psychosis and continues in early years of the disease. Previous 
studies identifying predictive and risk factors associated with suicidality in first-episode psychosis (FEP) are highly 
inconsistent. Also, there are relatively few longitudinal studies on suicidal behaviour in FEP. The aim of this study was 
to examine prevalence, evolution and predictors of suicidal behaviour at baseline and the 12-month follow-up in 
patients presenting with FEP.
Methods: One hundred and eighteen patients presenting with FEP were recruited from two early psychosis units in 
Portugal. A comprehensive assessment examining socio-demographic and clinical characteristics was administered 
at baseline and the 12-month follow-up. Odds ratio were calculated using logistic regression analyses. McNemar test 
was used to evaluate the evolution of suicidal behaviour and depression prevalence from baseline to 12 months of 
follow-up.
Results: Follow-up data were available for 60 participants from the 118 recruited. Approximately 25.4% of the 
patients had suicidal behaviour at the baseline evaluation, with a significant reduction during the follow-up period 
to 13.3% (p = 0.035). A multivariate binary logistic regression showed that a history of suicidal behaviour and depres-
sion at baseline independently predicted suicidal behaviour at baseline, and a history of suicidal behaviour and low 
levels of total cholesterol predicted suicidal behaviour at the 12-month follow-up. A significant proportion of patients 
also had depression at the baseline evaluation (43.3%), with the last month of suicidal behaviour at baseline indepen-
dently predicting depression at this time.
Conclusions: The findings of our study indicate that suicidal behaviour was prevalent on the year after FEP. Patients 
with a history of suicidal behaviour, depression at baseline and low levels of cholesterol should undergo close evalua-
tion, monitoring and possible intervention in order to reduce suicide risk in the early phases of psychosis.
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Background
Suicide and cardiovascular disorders are the two main 
causes of excess or premature death in psychotic patients 
[1]. About 5% of patients with schizophrenia die by sui-
cide, and about 50% have suicidal ideation or attempt 
suicide [2, 3]. Suicide risk differs across the various 
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stages of the disorder, with the highest rates occurring in 
the early phases [4]. Recent studies found that this sui-
cide risk begins at ultra-high risk of psychosis (UHR) 
stage and continues in early years of the disease [5, 6]. 
Patients experiencing first-episode psychosis (FEP) have 
a 60% increased risk of suicide in the first year of treat-
ment compared with those in subsequent phases [7]. The 
prevalence of suicidal ideation, a consistent antecedent 
of suicidal behaviour (attempts and completed suicide), 
ranges from 26.2% to 56.5% during the initial presenta-
tion of FEP [8, 9]. The prevalence of suicide attempts in 
the years following FEP ranges from 2.9% to 18.2% and 
suicide from 0.4% to 4.29% [10].
Therefore, the first years of psychotic disorders rep-
resent an important challenge for Public Health and 
Psychiatry. Consequently, researchers have sought to 
identify predictive and risk factors associated with sui-
cidality in FEP; however, the findings are highly incon-
sistent. Younger age of onset of psychosis [8, 11, 12] and 
drug and alcohol use [13–15] are factors associated with 
suicidality in FEP. As in the general population, previous 
suicidal behaviour, e.g. suicide attempts, has been identi-
fied as one of the most significant predictors of suicidal 
risk in FEP [16–18]. However, while results are mixed 
regarding gender [8, 11, 19–24], duration of untreated 
psychosis [7, 8, 22], positive psychotic symptoms [7, 25, 
26] and insight [8, 15, 24, 27–29], treatment compliance 
has been demonstrated to reduce suicide risk [30].
Current or past significant depressive symptoms are 
associated with suicide risk in patients after FEP [15, 
31–34]. The prevalence of depressive symptoms after 
FEP ranges from 14.15% to 44.80%. Studies evidenced 
that depressive symptoms diminished with follow-
up time and treatment, but remained significant even 
10  years after FEP [10, 35]. Previous studies showed 
that the most depressive symptoms occur either in pro-
drome [36] or during FEP [37, 38]. Rarely do depressive 
symptoms occur de novo in recovery following FEP [31]. 
Usually, depressive symptoms follow the course of posi-
tive psychotic symptoms and remit with antipsychotic 
treatment [39], although there are some patients with 
psychosis who maintain persistent depressive symptoms 
beyond the acute phase and do not respond to antipsy-
chotic treatment. Co-morbid depression and psychosis 
increase the risk of suicidality and relapse [40, 41]. It has 
been suggested that early identification and intervention 
for depression in the early phases of psychosis may con-
stitute an important strategy in the prevention of suicide 
[4, 42].
Published studies suggest that early intervention 
services—including short treatment delays, main-
taining adherence to therapy and specialised pro-
grammes—reduce the risk of suicide [43, 44], which is an 
important aim of early intervention teams. Despite the 
relevance of this theme, there are relatively few longitudi-
nal studies on suicidal behaviour in FEP and early phases 
of psychosis. Additionally, published studies have some 
methodological limitations that we tried to overcome. 
First, many published studies only included first-episode 
schizophrenia patients [12, 29, 45]. It is known that a 
diagnosis of FEP is unstable, with the likelihood of subse-
quent changes in the first years of the illness [46]. There-
fore, it is suggested that studying a broader diagnostic 
sample of FEP with affective and non-affective psychosis 
would be more accurate in estimating suicidal behaviour. 
Second, some studies included heterogeneous samples 
that mixed patients at different stages of their illness, 
including chronic and early psychosis patients. Third, 
many past studies only included hospitalised patients, 
excluding milder forms of psychotic disorders. Fourth, 
most previous studies used retrospective or cross-sec-
tional designs, which are characterised by inherent diffi-
culties in establishing predictive factors.
Greater understanding and knowledge around sui-
cide risk profiles and predictors of suicide in psychotic 
patients will enable the development of preventive strat-
egies. Appropriate monitoring and managing of suicide 
risk will be important for services working with early 
psychosis populations. Prospective studies in patients 
with FEP are necessary to better identify predictive and 
risk factors for suicidal behaviour in early psychosis. 
The prevalence and methods of suicidal behaviour dif-
fer between countries and cultures. The literature indi-
cates that socio-cultural factors and healthcare resources 
may condition the risk of suicide [47–49]. Therefore, it is 
important to have studies from different countries and 
cultures.
The main aims of this study were: (1) to examine the 
prevalence and evolution of suicidal behaviour soon 
after FEP (baseline) and 12  months of follow-up and 
(2) to determine baseline predictors of suicidal behav-
iour soon after FEP and at the 12-month follow-up. We 
also examined the prevalence of depression, its evolu-
tion in the 12 months following FEP and the predictors 
of depression at baseline and follow-up. We hypoth-
esised that affective psychosis, previous suicidal behav-
iour and depressive symptoms at baseline would predict 




The study was carried out at two specialist psychiat-
ric services within Portuguese hospitals: Hospital Vila 
Franca de Xira (in Vila Franca de Xira with a catch-
ment area of 245.000 individuals) and Centro Hospitalar 
Page 3 of 11Coentre et al. Ann Gen Psychiatry           (2021) 20:35  
Universitário Lisboa Norte (in Lisbon with a catchment 
area of 350.000 individuals). The selected patients were 
from two early intervention teams: the First-Episode Psy-
chosis Program (PPEP) at Hospital Vila Franca de Xira 
(Vila Franca de Xira) and Programa de Intervenção nas 
Fases Iniciais da Psicose (PROFIP) at Centro Hospitalar 
Universitário Lisboa Norte (Lisbon). Both programmes 
are comprehensive, specialised mental health services 
for FEP patients originating from geographically defined 
catchment areas in Vila Franca de Xira and north region 
of Lisbon, Portugal. Vila Franca de Xira Hospital is a sec-
ondary care general hospital in the north metropolitan 
area of Lisbon. Centro Hospitalar Universitário Lisboa 
Norte is a tertiary care general university hospital, which 
interacts closely with the Faculty of Medicine, University 
of Lisbon. The populations served by the two hospitals 
live mainly in the suburban and urban areas, respectively, 
of the metropolitan region of Lisbon. A description of the 
PROFIP programme was published elsewhere [50].
All FEP patients underwent an assessment by trained 
personnel as soon as possible after contact with the team. 
The mean length from service entry to baseline assess-
ment was 5.7 days (SD: 1.8). The programmes consisted 
of low-dose second-generation antipsychotic medication 
and individual and group psychosocial treatment, namely 
family intervention.
The participants met the following inclusion criteria 
at baseline: (1) age between 16 and 40 years; (2) DSM-IV 
(American Psychiatric Association, 1994) diagnosis of a 
psychotic disorder (schizophrenia, schizophreniform dis-
order, schizoaffective disorder, delusional disorder, bipo-
lar psychotic disorder, major depressive disorder with 
psychotic features, brief psychotic disorder, cannabis-
induced psychosis and psychosis not otherwise speci-
fied); (3) living in the geographical catchment of the PPEP 
or PROFIP services; (4) adequate comprehension of Por-
tuguese language; (5) experiencing FEP with less than 6 
months of antipsychotic medication. Exclusion criteria at 
baseline included: (1) head injury, neurological illness, or 
any other medical condition presenting with psychiatric 
symptoms (2) history of past full-blown psychotic epi-
sodes, either non-affective or affective, as defined in the 
Diagnostic and Statistical Manual of Mental Disorders, 
IV Edition (American Psychiatric Association, 1994); (3) 
inability to understand and complete the assessments.
The study included all eligible consecutive patients 
who met the study criteria for the period January 2017 
to April 2020. The patients were evaluated at two time 
points: a baseline evaluation after the clinical stabilisa-
tion of FEP; 12  months after the baseline assessment. 
Follow-up data were available for 60 participants from 
the 118 recruited. The study complied with the ethical 
principles of good practice embodied in the Declaration 
of Helsinki. Responsible ethical committees within both 
hospitals approved the study, and all participants pro-
vided informed consent.
Clinical assessments
The clinical assessment included evaluations regard-
ing socio-demographics and clinical data, including age, 
marital status, education, occupational status, living area 
(urban or rural), medical history, education, family his-
tory of mental illness, presence of stressful life events 
occurring in the past year before entering the study, 
mode of onset of FEP, substance use and type and dose 
of antipsychotic medication. The baseline and 12-month 
follow-up diagnoses were obtained using all available 
information, including informant history and medical 
records. The Operational Criteria Checklist for Psychotic 
Illness and Affective Illness (OPCRIT +) instrument was 
used to obtain the diagnosis [51, 52]. The checklist ratings 
were entered into the OPCRIT + software, which gener-
ates a diagnosis for the main categories of affective and 
psychotic disorders, as defined by the DSM-IV, which is 
the major classification system. The duration of untreated 
psychosis (DUP) was measured using the Nottingham 
Onset Schedule (NOS) [53]. DUP was defined as the 
period of time between the onset of psychotic symptoms 
and the initiation of treatment with antipsychotic medi-
cation. Symptom levels were evaluated using means of 
the three subscales used to evaluate positive symptoms, 
negative symptoms and the general psychopathology of 
the Positive and Negative Syndrome Scale (PANSS) [54]. 
Suicidal behaviour was assessed at baseline and follow-up 
evaluations using an instrument developed by Melle [18], 
which consists in three questions about the last month 
and lifetime suicidal thoughts, plans or attempts.
The information was cross-checked with the medical 
records. “Suicidal thoughts” were considered a preoccu-
pation or recurrent thoughts of suicide without a specific 
plan. “Suicide plans” were considered as the presence of a 
specific plan to suicide. “Suicide attempts” were defined 
as a self-non-fatal act with a suicidal intent. The most 
severe form of suicidal behaviour reported for a lifetime 
or the past month was registered.
The baseline and 12-month follow-up assessments of 
depressive symptoms were conducted using the Beck 
Depression Inventory (BDI). The BDI is a widely used 
self-report questionnaire designed to measure the sever-
ity of depression in individuals between the ages of 13 
and 80 years. It contains 21 items, which are rated on a 
four-point scale according to how the patients felt in 
the previous two weeks. The scores obtained for the sin-
gle item are summed to provide a single total score. We 
used 14 as the global cut-off score to determine patients’ 
depression (depression ≥ 14). We used the Portuguese 
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version, which was translated into Portuguese and 
adapted to the Portuguese population [55–57].
For the alcohol screening, the Michigan Alcohol 
Screening Test (MAST) was used. This is a 22-item 
self-questionnaire requiring yes/no answers, with one 
point each. A total score of 6 or more indicates hazard-
ous alcohol consumption or alcohol dependence. The 
Portuguese-translated version, which was adapted to the 
Portuguese population, has been used before [58, 59]. 
Functioning was measured using the Global Assessment 
of Functioning Scale (GAF) [60]. Adherence to medica-
tion was evaluated by Medication Adherence Rating 
Scale (MARS). The MARS is a ten-item self-report meas-
ure of medication adherence in psychosis [61]. The total 
score ranges from 0 to 10 with a higher score indicating 
better adherence. We used the translated and validated 
scale to the Portuguese population [62].
Statistical analysis
Statistical analyses were conducted using the Statisti-
cal Package for Social Science (SPSS), version 26 (Inc, 
2020). Due to non-normality in all the explored statistics, 
non-parametric tests were used. In the between-group 
comparisons, categorical variables were examined using 
Chi-square or Fisher’s exact test (if 20% of expected fre-
quency was ≤ 5 or any expected frequency was < 1) and 
continuous variables with the Mann–Whitney U test.
The primary analysis of this study focused on identify-
ing factors predicting the occurrence of suicidal behav-
iour at baseline and 12  months after the occurrence of 
FEP. We also evaluated the predictors of depression in 
FEP patients (at baseline and 12 months after FEP). Sui-
cidal ideation/behaviour was collapsed into a binary 
variable suicidal/non-suicidal (i.e. presence/absence of 
suicidal thoughts, plans or attempts). We also considered 
depressive/not depressive as well as the above-mentioned 
cut-off on the BDI scale. First, a univariate binary logis-
tic regression was conducted, with suicidal behaviour 
as the dependent variable and demographic and clinical 
variables as the candidate predictors. Second, variables 
with a significant p value in the preceding analysis were 
then entered into a multivariate binary regression model 
to determine which factors independently predicted sui-
cidal behaviour at baseline and the 12-month follow-up. 
A stepwise method was used with a forward selection 
of predictors. The same procedure was conducted, with 
depression as the dependent variable. Collinearity evalu-
ations were performed by examining correlation matri-
ces for all the variables, tolerance and variance inflation 
factors.
We used the McNemar test to evaluate the evolution 
of suicidal behaviour and depression and compare the 
results at baseline with those at 12 months. The Wilcoxon 
test for repeated measures was used to evaluate the evo-
lution of depression from the BDI mean score. The level 
of statistical significance was set at p < 0.05.
Results
Characteristics of the sample
The sample comprised 118 patients consecutively admit-
ted to PPEP (n = 39) and PROFIP (n = 79). There were no 
differences between the two groups in terms of sex and 
employment. The patients from the PROFIP team were 
younger (mean years 24.2 vs. 29.61; p = 0.003) and of a 
higher educational level (mean years of education 11.7 
vs. 10.1; p = 0.016) (Mann–Whitney U-test for both). Of 
the 118 participants included in the study, 76.3% (n = 90) 
were male. The mean age of the sample at intake was 
26.1 years (SD = 7.1). The majority (49.2%) of the patients 
were diagnosed with schizophrenia spectrum disorders 
(schizophrenia: n = 48; delusional disorder: n = 8; schiz-
oaffective disorder: n = 2). Thirty-nine (33%) were diag-
nosed with other psychosis diagnosis, with 8 patients 
with a brief psychotic disorder, 23 with a non-specified 
diagnosis of psychosis and 8 with a cannabis-induced 
psychosis diagnosis. Twenty-one (17.8%) participants had 
affective psychosis (n = 8 had bipolar affective disorder 
with psychotic features, and n = 13 had major depression 
with psychotic features). Table 1 shows the socio-demo-
graphic and clinical baseline variables of the sample.
Of the initial cohort of 118 patients who completed the 
baseline assessment, 60 completed the follow-up assess-
ment. We lost contact with 58 patients for the following 
reasons: 30 moved to other catchment areas in Portugal; 
15 moved to other countries and 13 could not be con-
tacted for the follow-up. Non-completers and completers 
groups had no significant differences regarding socio-
demographics and clinical variables, with the exception 
of more males (p = 0.009) and lower affective psychosis 
diagnoses (p = 0.030) on the non-completers group.
Comparisons of socio-demographics and clinical char-
acteristics between the affective psychosis and schizo-
phrenia spectrum disorder diagnoses are shown in 
Additional file 1: Table S1.
Prevalence of suicidal behaviour
Forty-two (35.6%) participants had a history of suicidal 
behaviour prior to entering the study, with 34.7% (n = 41) 
of the cohort having suicidal ideation, 17.80% (n = 21) 
suicidal plans and 9.32% (n = 11) a suicide attempt. 
Overdose of medication was the most frequently used 
attempted suicide method (54.5%)), followed by jumping 
from a height (18.2%), strangulation (18.2%) and phlebot-
omy (9.1%).
Page 5 of 11Coentre et al. Ann Gen Psychiatry           (2021) 20:35  
For the total initial FEP group, suicidal behaviour 
in the last month was found for 25.4% (n = 30) of the 
cohort, with 15.3% of them experiencing suicidal idea-
tion, 4.2% suicidal plans and 5.9% suicide attempts. The 
most frequently used methods of attempted suicide in 
the last month were overdose of medication, jumping 
from a height and hanging (1.7% in each group). One 
patient attempted suicide through phlebotomy.
For the participants who completed the 12-month eval-
uation, 13.3% (n = 8) had suicidal behaviour, 8.3% suicidal 
ideation, 3.3% suicidal plan and 1.7% a suicide attempt. 
The only suicide attempt was overdose of medication.
Twelve patients (40%) who reported suicidal behaviour 
at baseline evaluation had no history of suicidal behav-
iour. Only one patient that reported suicidal behaviour at 
follow-up evaluation had no history of suicidal behaviour.
With regard to the longitudinal evolution of sui-
cidal behaviour, a statistically significant decrease at 
the 12-month follow-up was found (25.4% vs. 13.3%; 
p = 0.035).
Univariate associations with suicidal behaviour
The associations of suicidal behaviour at baseline and 
12 months of follow-up with the demographic and clini-
cal factors are shown in Table  2. Patients with suicidal 
behaviour at baseline were significantly more likely to 
have a history of suicidal behaviour, baseline affective 
psychosis diagnosis and baseline depression. Suicidal 
behaviour patients at 12 months of follow-up were found 
to have a significantly greater history of suicidal behav-
iour at baseline, baseline suicidal behaviour in the last 
month and lower total cholesterol at baseline.
Predictors of suicidal behaviour in the multivariate model
A multivariate binary logistic regression analysis showed 
that a history of suicidal behaviour and depression at 
baseline predicted suicidal behaviour at baseline. A his-
tory of suicidal behaviour and low baseline total cho-
lesterol predicted suicidal behaviour at 12  months of 
follow-up (Table 3).
Prevalence and predictors of depression
The longitudinal evolution of depression prevalence 
showed a significant decrease between baseline and the 
12-month follow-up (43.3% vs. 20.0%; p = 0.014).
A univariate analysis of predictors of baseline depres-
sion revealed that depressed patients had a signifi-
cantly higher history of suicidal behavioural (OR: 2.29; 
p = 0.035). Also, depressed patients at baseline had a 
higher prevalence of suicidal behaviour in the last month 
(OR: 3.50; p = 0.005), which was the only variable that 
maintained a statistical significance in the multivariate 
analysis (OR: 2.94; 95% IC: 1.19–7.27; p = 0.020). None of 
socio-demographic or clinical baseline factors analysed 
reach statistical significance in the multivariate analysis, 
with 12 months of depression as the dependent variable.
Discussion
To the best of our knowledge, this is the first study to 
examine the prevalence and socio-demographic and 
clinical characteristics of FEP with and without suicidal 
Table 1 Socio-demographic and clinical baseline variables of 
the sample
SD standard deviation, DUP duration of untreated psychosis, PANSS Positive 
and Negative Syndrome Scale, GAF Global Assessment of Functioning, BDI Beck 
Depression Inventory, MARS Medication Adherence Rating Scale
Schizophrenia-spectrum disorder included schizophrenia, schizophreniform 
disorder, delusional disorder and schizoaffective disorder. Affective psychosis 
included bipolar disorder with psychotic symptoms and depressive disorder 
with psychotic symptoms. Other psychosis included acute and transient 
psychotic disorders, brief psychotic disorder, cannabis-induced psychosis and 





Age years—mean (SD) 26.1 (7.10)
Gender—n (%)
 Female 28 (23.7%)
 Male 90 (76.3%)
Education years—mean (SD) 11.24 (3.2)
Unemployment—n (%) 51 (43.2%)
Marital status—n (%)
 Living with partner/married 14 (11.9%)
 Single/divorced 104 (88.1%)
Hospitalisation baseline—n (%)
 Yes 101 (85.6%)
 No 17 (14.4%)
Cannabis use—n (%)
 Yes 75 (63.6%)
 No 43 (36.4%)
Psychiatric family history—n (%) 76 (64.4%)
DUP – days, median (SD) 84 (643.3)
Diagnoses—n (%)
 Schizophrenia spectrum diagnosis 58 (49.2%)
 Affective psychosis spectrum diagnosis 21 (17.8%)
 Other psychosis diagnosis 39 (33%)
PANSS score—mean (SD)
 PANSS positive subscale 21.24 (8.09)
 PANSS negative subscale 15.86 (7.41)
 PANSS general subscale 35.97 (8.80)
GAF—mean (SD) 43.40 (18.28)
BDI—mean (SD) 13.18 (10.10)
MARS—mean (SD) 6.08 (2.26)
Total Cholesterol mg/dL—mean (SD) 153.43 (31.72)
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Table 2 Demographic, pre-treatment and baseline predictors of suicidal behaviour
Variables of 
interest























21(70.0)/9(30.0) 69(78.4)/19(21.6) 1.56 (0.61–3.95) 0.352 4 (50.0)/4 (50.0) 36/16 2.25 (0.50–10.14) 0.291
 Age at entry, 
mean (SD)
26.83 (7.49) 25 (7.01) 0.98 (0.93–1.04) 0.504 30.13 (9.91) 26.63 (7.60) 0.95 (0.87–1.04) 0.252
 Years of educa-
tion, mean 
(SD)
11.10 (3.60) 11.28 (3.01) 1.02 (0.89–1.16) 0.786 11.88 (3.56) 11.19 (3.33) 0.94 (0.75–1.18) 0.588
 Married/with 
partner, n (%)
5 (16.7) 9 (10.2) 1.76 (0.54–5.73) 0.351 1 (12.5) 7 (13.46) 1.34 (0.14–13.25) 0.801
 Living alone, 
n (%)
1 (3.3) 11 (12.5) 0.24 (0.03–1.95) 0.183 0 (0) 8 (15.38) 0.000 0.999
 Employed/stu-
dent, n (%)
16 (53.3) 51 (57.9) 0.83 (0.36–1.91) 0.659 6 (75.0) 2 (3.85) 2.20 (0.41–11.95) 0.361
Pre-treatment illness characteristics
 Family history 
of mental dis-
order, n (%)
20 (66.67) 56 (63.6) 1.14 (0.48–2.74) 0.765 7 (87.5) 1 (1.92) 3.11 (0.35–27.43) 0.307




18 (60.0) 24 (27.3) 4.00 (1.68–9.53) 0.002 7 (87.5) 1 (1.92) 13.22 (1.51–116.01) 0.020
 History of sub-
stance use, 
n (%)
20 (66.67) 55 (62.5) 1.20 (0.50–2.87) 0.682 6 (75.0) 2 (3.85) 2.03 (0.37–11.05) 0.412
 History of alco-
hol abuse, 
n (%)
15 (50.0) 37 (42.0) 1.38 (0.60–3.17) 0.449 3 (37.5) 5 (9.62) 0.89 (0.19–4.11) 0.877
Baseline clinical characteristics
 DUP, median 
(SD) days
28.00 (984.61) 92.00 (473.95) 1.00 (0.99–1.00) 0.204 19 (114.55) 98 (770.42) 1.00 (0.99–1.01) 0.291
 Hospitalisation, 
n (%)
27 (90.0) 74 (55.7) 1.70 (0.45–6.40) 0.430 0 (0.0) 8 (15.38) 0.000 0.999
 Tobacco use, 
n (%)











11 (36.67) 47 (53.4) 0.51 (0.21–1.18) 0.116 2 (25.0) 6 (11.54) 0.29 (0.05–1.55) 0.146
 Affective psy-
chosis, n (%)
9 (30.0) 12 (12.6) 2.71 (1.01–7.31) 0.048 4 (50.0) 4 (7.69) 3.33 (0.72–15.37) 1.123
 Other psycho-
sis, n (%)
8 (26.7) 29 (32.9) 0.74 (0.29–1.86) 0.522 2 (25.0) 6 (11.54) 1.11 (0.19–6.24) 0.905
Symptom severity and functioning
 PANSS positive 
symptoms, 
mean (SD)
20.67 (8.05) 21.43 (8.14) 1.01 (0.96–1.07) 0.653 20.63 (7.84) 18.85 (7.29) 0.97 (0.88–1.07) 0.521
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behaviour in a Portuguese population. The present study 
examined the evolution of the prevalence of suicidal 
behaviour in the 12 months after FEP in a cohort of Por-
tuguese young people. We also aimed to identify early 
predictors of suicide behaviour at 12 months of follow-up 
(baseline and 12 months). In our present study, the prev-
alence of suicidal behaviour was 25.4% soon after FEP. 
This is in line with existing studies which showed that 
approximately 25% to 50% of FEP patients reported sui-
cidal behaviour at initial presentation [7, 20, 31, 63]. We 
also confirmed that a history of suicidal behaviour before 
service entry in FEP patients was a predictor of suicidal 























OR (95% CI) p value
 PANSS negative 
symptoms, 
mean (SD)
17.53 (8.48) 15.30 (6.98) 0.96 (0.91–1.01) 0.155 17.88 (6.643) 17.31 (7.237) 0.99 (0.89–1.09) 0.832
 PANSS general 
symptoms, 
mean (SD)
39.07 (9.81) 34.91 (8.22) 0.95 (0.90–0.99) 0.031 39.63 (6.02) 35.69 (9.34) 0.96 (0.89–1.03) 0.260
 BDI, mean (SD) 18.47 (11.434) 11.42 (8.93) 0.93 (0.89–0.97) 0.002 20.50 (12.11) 12.48 (9.87) 0.93 (0.87–1.00) 0.054
 Depression, 
n (%)
20 (66.7) 32 (36.4) 3.50 (1.46–8.39) 0.005 6 (75.0) 2 (3.85) 4.80 (0.88–26.14) 0.070
 GAF, mean (SD) 44.17 (17.52) 43.14 (18,62) 0.99 (0.97–1.02) 0.789 43.75 (15.53) 48.00 (17.60) 1.01 (0.97–1.06) 0.516
 MARS, mean 
(SD)




154.50 (32.56) 153.07 (31.62) 0.999 (0.986–
1.012)
0.830 170.88 (26.2) 146.17 
(30.518)
0.97 (0.95–0.99) 0.045
DUP  duration of untreated psychosis, PANSS  Positive and Negative Syndrome Scale, BDI  Beck Depression Inventory, GAF  Global Assessment of Functioning, 
MARS  Medication Adherence Rating Scale, SD  standard deviation
Schizophrenia-spectrum disorder included schizophrenia, schizophreniform disorder, delusional disorder and schizoaffective disorder
Affective psychosis included bipolar disorder with psychotic symptoms and depressive disorder with psychotic symptoms
Other psychosis included acute and transient psychotic disorders, brief psychotic disorder, cannabis-induced psychosis and psychosis not otherwise specified
Table 3 Multivariate logistic regression analysis for predictors of baseline and 12-month suicidal behaviour in first-episode psychosis 
 patientsa,b
a Affective psychosis diagnosis and PANSS general were entered into stepwise logistic regression model, were excluded as predictors of baseline suicidal behaviour
b Last month baseline suicidal behaviour were entered into stepwise logistic regression, were excluded as predictors of 12-month suicidal behaviour
Variables in the equation B SE Wald df p value OR 95% CI
Baseline
 Depression baseline 1.087 0.463 5.514 1 0.019 2.96 1.20–7.34
 History of suicide behaviour 1.237 0.456 7.343 1 0.007 3.44 1.41–8.43
 Constant − 0.153 0.367 0.175 1 0.676 0.86
Final model: Nagelkerke  R2 = 0.185, χ2 = 15.850, p < 0.0001
Hosmer and Lemeshow test supported the goodness of fit of the model (χ2 = 0.006, df = 2, p = 0.997)
12-month follow-up
 History of suicide behaviour 2.849 1.172 5.910 1 0.015 17.27 1.74–171.65
 Total cholesterol baseline − 0.030 0.014 4.411 1 0.036 0.97 0.94–0.99
 Constant 5.643 2.369 5.674 1 0.017 282.31
Final model: Nagelkerke  R2 = 0.373, χ2 = 13.600, p = 0.001
Hosmer and Lemeshow test supported the goodness of fit of the model (χ2 = 12.657, df = 8, p = 0.124)
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consistent with previous first-episode studies from other 
countries [47, 64, 65].
As previous published studies showed, we also con-
firmed that depression was associated with suicidal 
behaviour [64–67]. Our results showed that depression 
was a predictor of suicidal behaviour at baseline. Using 
the univariate analysis, baseline depression was also 
almost significant as predictor of suicidal behaviour at 
follow-up (p = 0.07). This result suggests that close evalu-
ation, monitoring and early intervention for depression 
in FEP are crucial to reducing suicidal behaviour in the 
early phases of psychosis.
Like our study, a majority of the literature did not find 
an association between negative symptoms and suicidal 
behaviour [15, 68]. Some studies postulated that patients 
with significant negative symptoms, namely deficits 
in emotion expressivity, are impaired from expressing 
emotional distress caused by psychosis, consequently 
reducing the probability of developing depression, hope-
lessness and suicidal behaviour [69]. In line with this, 
a few studies found negative symptom severity to be 
inversely related to the risk of suicidal ideation and sui-
cide attempts [65, 67].
Regarding positive symptoms, we failed to demonstrate 
that these symptoms were predictors of suicidal behav-
iour, contrary to some prior FEP studies [14, 26]. Our 
results were similar to those found in other published 
studies where no predictability was found [47].
An interesting finding of our study is that high levels 
of total cholesterol were a baseline protector of suicidal 
behaviour at follow-up. This is in concordance with 
research in this field of knowledge. Published studies 
seem to demonstrate an association between low cho-
lesterol and an increased risk of suicide in non-psychotic 
patients as well as in psychosis [70–74]. There is a dearth 
of research on the relationship between cholesterol lev-
els and suicidality in FEP. One study found that serum 
cholesterol concentrations were significantly lower in 
suicidal than in non-suicidal patients in FEP, suggest-
ing that lower concentrations of serum cholesterol in 
patients with FEP might be useful as a biological marker 
of suicidality [70]. Another study in early psychosis dem-
onstrated that lower levels of cholesterol in patients of 
psychosis were associated with severe suicidal thoughts 
[72]. The exact mechanisms of the relationship between 
peripheral cholesterol, brain metabolism and suicidal 
behaviour are not entirely known. Some authors have 
suggested an existing abnormality in leptin and lipid 
metabolism in suicidal behaviour [75]. Moreover, post-
mortem brain studies have indicated that violent suicide 
completers have lower grey-matter cholesterol content, 
specifically in the frontal cortex [76]. We only included 
total cholesterol because this metabolic parameter is the 
only one with previous studies showing association with 
suicidal behaviour.
Our findings also indicate that a baseline affective psy-
chosis diagnosis and a high score on the PANSS general 
subscale were potential predictors of baseline suicidal 
behaviour; however, these results did not reach signifi-
cant statistical significance in the multivariate analysis. 
Affective psychosis, which includes major depressive 
disorder with psychotic symptoms, is a diagnosis asso-
ciated with suicidal behaviour. The low proportion of 
patients included with affective psychosis (17.8%) could 
explain the non-statistical significance of this diagnosis 
in the multivariate analysis. The PANSS general subscale 
was composed of 16 items evaluating other symptoms, 
including depressive symptoms. We argue that these 
items conditioned the result obtained.
The present study also showed the high frequency of 
depression and depressive symptoms in the first year 
after FEP. Almost half of the patients were depressed at 
baseline, while one-fifth had depression at one year of 
follow-up. As indicated in the BDI score, the depressive 
symptoms significantly decreased during the first year 
after FEP. This is also similar to other published studies 
[31, 77–79]. Some authors have speculated several path-
ways to depression in psychosis, namely in schizophre-
nia. Three possible explanations exist: (1) depression as 
an intrinsic aspect of the psychotic disorder; (2) depres-
sion as a result of the psychotic illness; (3) depression as a 
result of disturbed developmental pathways [80].
Our findings did not confirm the idea that depressive 
symptoms in schizophrenia are frequently misdiagnosed 
with negative symptoms [81]. In this case, high lev-
els of depressive symptoms would exist simultaneously 
with high levels of negative symptoms, and a significant 
association between negative and depressive symptoms 
would have been expected, which did not happen in our 
study.
The only predictors that we found to be significant 
to depression at baseline were baseline suicidal behav-
iour in the last month and a history of suicidal behav-
iour. Surprisingly, we found no significant baseline 
predictors of depression at 12  months. Contrary to 
our findings, other studies found that a long DUP and 
depressive symptoms at baseline predict depressive 
symptoms at 12  months of follow-up [77, 82]. Also, 
some studies found an association between depres-
sion scores and positive symptoms and an improve-
ment with successful antipsychotic therapy [39, 83]. 
However, some studies also failed to find this asso-
ciation, indicating that depressive symptoms may also 
emerge independently of positive symptoms [84, 85]. 
The reasons for our study’s failure in finding signifi-
cant baseline predictors at the 12-month follow-up are 
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not immediately apparent. We could speculate that our 
baseline evaluation, which was conducted only after a 
clinical stabilisation of FEP, might have been a little late 
for significant findings.
Several clinical implications can be drawn from our 
results. First, at service entry, a significant proportion of 
patients had a history of suicidal behaviour and suicidal 
behaviour in the last month. Thus, at the intake of early 
intervention teams, all patients should undergo a suicide 
risk assessment. For those at high risk or experience of 
previous suicidal behaviour, more intensive monitor-
ing and intervention should be offered. Second, given 
that baseline depression was found to be a predictor of 
suicidal behaviour, routine assessments for depression 
should be offered in early intervention teams, and for 
those with positive screening, close monitoring of the 
emergence of suicidal behaviour and adequate treatment 
should be offered. Third, our results also indicate that 
an evaluation of total cholesterol should be included in 
the baseline evaluation of FEP patients, not only for the 
metabolic evaluation but also as a potential predictor of 
suicidal behaviour. Therefore, patients with low choles-
terol should be screened and closely monitoring for the 
existence and emergence of suicidal behaviour.
The results of this study should be interpreted with 
some methodological limitations in mind. First, the eval-
uation of suicidal behaviour (including suicidal ideation, 
suicide plan and suicide attempt) was mainly obtained 
from the participants’ self-reports and, thus, was subject 
to the problem of under-reporting. Second, standardised 
classification algorithms for suicidal intent, attempts and 
completed suicides were not used in this research. These 
algorithms were found to enhance the reliability of the 
suicidal behaviour assessment. Third, the relatively high 
proportion of follow-up losses from 118 participants at 
baseline to 60 at the 12-month follow-up could have lim-
ited the results by reducing in some extension the statisti-
cal power of the results. Fourth, we studied the predictors 
of suicidal behaviour, including suicidal ideation, plans 
and attempts, as a whole group. It was hypothesised that 
predictors of suicidal ideation, suicide plans and attempts 
might differ. Fifth, the low numbers obtained regarding 
suicidal behaviour during follow-up, namely no com-
pleted suicide and only 13.3% of participants reporting 
suicidal behaviour at the 12-month follow-up evaluation. 
These numbers compromised the statistical power of the 
study, which could explain the non-significant associa-
tions with sex, age of FEP and DUP in our study. Sixth, 
other important variables that might be potential predic-
tors of suicidal behaviour were not studied because of the 
difficulties involved in obtaining them, including child-
hood abuse or previous trauma.
Conclusions
Our results showed that a large proportion of FEP 
patients had a history of suicidal behaviour or had cur-
rent baseline suicidal behaviour. We also verified that 
depression was prevalent in the 12 months after FEP. Our 
results are in line with those of previous studies, confirm-
ing that a history of suicidal behaviour and depression 
soon after FEP are associated with suicidal behaviour in 
the early months after FEP. These findings are important 
for the development of early intervention programmes to 
lower the risk of suicide and depression in FEP patients. 
Our finding regarding the predictive role of baseline total 
cholesterol should be investigated in further prospective 
research to determine whether our result was predictive 
of suicidal behaviour.
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